Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | Chief Commercial Officer | May 22, 2020 | May 26, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date May 22, 2020 · Filed May 26, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,180 |
Reported balance
After 2020-05-22 transaction · row 1
1 source rowRow 1 · 2020-05-22 · Tax withholding · Disposed 2,675 · Balance 144,180 F1: Represents the weighted average sale price. The highest price at which shares were sold was $1.96 and the lowest price at which shares were sold was $1.94. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sale price. The highest price at which shares were sold was $1.96 and the lowest price at which shares were sold was $1.94. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2020 Filed May 26, 2020 20:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | Tax withholdingCommon Stock | 2,675 | $1.94 | $5,189.50 |
DisclosureSEC source: 0001192482-20-000370 · edgar.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,180 F1 · price: Represents the weighted average sale price. The highest price at which shares were sold was $1.96 and the lowest price at which shares were sold was $1.94. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| March 12, 2020 Filed Mar 13, 2020 20:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 5,000 | $2.36 | $11,800.00 |
DisclosureSEC source: 0001192482-20-000228 · edgar.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,855 F1 · price: Represents the weighted average purchase price. The highest price at which shares were purchased was $2.3625 and the lowest price at which shares were purchased was $2.35. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions reported on this Form 4. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:38 UTC | Neuronetics, Inc. STIM · Entity 6248 | Tax withholdingCommon Stock | 719 | $2.01 | $1,445.19 |
DisclosureSEC source: 0001192482-20-000218 · edgar.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,855 Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 56,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000198 · edgar.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,574 F1 · shares: Represents a restricted stock unit ("RSU") award of which 1/3 vests on each of the first, second and third anniversaries of the date of grant, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:29 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 37,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-004007 · doc4.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,074 F1 · shares: One-third (1/3rd) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of January 15, 2021, January 15, 2022 and January 15, 2023, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 21:10 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 2,500 | $4.28 | $10,700.00 |
DisclosureSEC source: 0001209191-19-058683 · doc4.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,074 Read SEC document |
| May 22, 2019 Filed May 23, 2019 20:54 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 3,685 | $14.53 | $53,543.05 |
DisclosureSEC source: 0001209191-19-032311 · doc4.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,574 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.30 to $14.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote (1) to this Form 4. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantEmployee Stock Option (right to buy) · Derivative | 15,005 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001209191-19-018609 · doc4.xml · derivative · entry 2 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,005 Underlying: Common Stock · 15,005 shares Expires 2029-03-08 F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 8,526 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018609 · doc4.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,259 F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 1,500 | $17.00 | $25,500.00 |
DisclosureSEC source: 0001209191-18-041645 · doc4.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,733 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.